Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice.

Genetically engineered murine models of Agl loss show that Agl deletion is permissive for bladder chemical carcinogenesis and provide the rationale for evaluating Agl expression in risk stratification of bladder cancer development in individuals with carcinogenic exposure such as smoking. Abstract Amylo--1,6-glucosidase,4--glucanotransferase (AGL) is an enzyme primarily responsible for glycogen debranching. Germline mutations lead to glycogen storage disease type III (GSDIII). We recently found AGL to be a tumor suppressor in xenograft models of human bladder cancer (BC) and low levels of AGL expression in BC are associated with poor patient prognosis. However, the impact of low AGL expression on the susceptibility of normal bladder to carcinogenesis is unknown. We address this gap by developing a germline Agl knockout (Agl(-/-)) mouse that recapitulates biochemical and histological features of GSDIII. Agl(-/-) mice exposed to N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) had a higher BC incidence compared with wild-type mice (Agl(+/+)). To determine if the increased BC incidence observed was due to decreased Agl expression in the urothelium specifically, we developed a urothelium-specific conditional Agl knockout (Agl(cko)) mouse using a Uroplakin II-Cre allele. BBN-induced carcinogenesis experiments repeated in Agl(cko) mice revealed that Agl(cko) mice had a higher BC incidence than control (Agl(fl/fl)) mice. RNA sequencing revealed that tumors from Agl(-/-) mice had 19 differentially expressed genes compared with control mice. An Agl Loss' gene signature was developed and found to successfully stratify normal and tumor samples in two BC patient datasets. These results support the role of AGL loss in promoting carcinogenesis and provide a rationale for evaluating Agl expression levels, or Agl Loss gene signature scores, in normal urothelium of populations at risk of BC development such as older male smokers.